NVTA Stock Price History and Quote Analysis: Insights for Investors
Invitae Corporation
Stock Price Today
Invitae Corporation (NVTA) stock declined over -35.59%, trading at $0.02 on NYSE, down from the previous close of $0.03. The stock opened at $0.02, fluctuating between $0.02 and $0.02 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
Company Information
| Employees | 1700 |
| Beta | 1.589 |
| Sales or Revenue | $516.30M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
Frequently Asked Questions
Invitae Corporation (NYSE: NVTA) stock price is $0.02 in the last trading session. During the trading session, NVTA stock reached the peak price of $0.02 while $0.02 was the lowest point it dropped to. The percentage change in NVTA stock occurred in the recent session was -35.59% while the dollar amount for the price change in NVTA stock was -$0.01.
The NYSE listed NVTA is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. Invitae Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Hoki Luk
Head of Investor Relations and Capital Markets
Glenn Medalle
Head of Talent
Mr. Kenneth D. Knight
Pres, Chief Executive Officer & Director
Ms. Yafei Wen
Chief Financial Officer
Mr. Thomas R. Brida
Gen. Counsel, Chief Compliance Officer & Sec.
Dr. Robert L. Nussbaum M.D.
Chief Medical Officer
Ms. Desarie French
Chief Talent Officer
Mr. Lee Bendekgey J.D.
Chief Policy Officer
Dr. W. Michael Korn M.D.
Chief Medical Officer
Mr. Jackson J. Finks C.F.A., CFA
Director of Investor Relations & Strategic Fin.
Dr. Randal W. Scott Ph.D.
Co-Founder & Chairman
Mr. Robert F. Werner
Chief Accounting & Principal Accounting Officer
Ms. Christine M. Gorjanc
Interim Chief Financial Officer & Director
Mr. Jeffrey Parsons
Interim Chief Accounting Officer
Ms. Shelly D. Guyer
Chief Sustainability Officer
NVTA's closing price is 26.67% higher than its 52-week low of $0.02 where as its distance from 52-week high of $2.34 is -99.19%.
Number of NVTA employees currently stands at 1,700.
Official Website of NVTA is: https://www.invitae.com
NVTA could be contacted at phone 415 374 7782 and can also be accessed through its website. NVTA operates from 1400 16th Street, San Francisco, CA 94103, United States.
NVTA stock volume for the day was 22.46M shares. The average number of NVTA shares traded daily for last 3 months was 12.7M.
The market value of NVTA currently stands at $5.44M with its latest stock price at $0.02 and 286.49M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com